UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,738,000 | -41.5% | 706,166 | 0.0% | 0.01% | -33.3% |
| Q2 2023 | $8,093,000 | -43.1% | 706,166 | 0.0% | 0.01% | -47.1% |
| Q1 2023 | $14,222,000 | -11.2% | 706,166 | 0.0% | 0.02% | -10.5% |
| Q4 2022 | $16,009,000 | +20.7% | 706,166 | -0.0% | 0.02% | +18.8% |
| Q3 2022 | $13,266,000 | +0.6% | 706,510 | -0.1% | 0.02% | +6.7% |
| Q2 2022 | $13,181,000 | +3.2% | 707,141 | 0.0% | 0.02% | +50.0% |
| Q1 2022 | $12,778,000 | -12.9% | 707,141 | 0.0% | 0.01% | -16.7% |
| Q4 2021 | $14,666,000 | -35.2% | 707,141 | 0.0% | 0.01% | -36.8% |
| Q3 2021 | $22,635,000 | +3.9% | 707,141 | 0.0% | 0.02% | +5.6% |
| Q2 2021 | $21,780,000 | -8.6% | 707,141 | 0.0% | 0.02% | -47.1% |
| Q1 2021 | $23,824,000 | -6.8% | 707,141 | -0.0% | 0.03% | -8.1% |
| Q4 2020 | $25,560,000 | -1.9% | 707,440 | 0.0% | 0.04% | -15.9% |
| Q3 2020 | $26,055,000 | -18.3% | 707,440 | 0.0% | 0.04% | -20.0% |
| Q2 2020 | $31,877,000 | -3.7% | 707,440 | +1.4% | 0.06% | -19.1% |
| Q1 2020 | $33,102,000 | -33.8% | 697,617 | 0.0% | 0.07% | -4.2% |
| Q4 2019 | $49,991,000 | +82.5% | 697,617 | +0.2% | 0.07% | +54.3% |
| Q3 2019 | $27,395,000 | -83.1% | 696,000 | -66.5% | 0.05% | -50.0% |
| Q2 2019 | $162,474,000 | +300.6% | 2,079,000 | +205.7% | 0.09% | +33.3% |
| Q1 2019 | $40,562,000 | +135.7% | 680,000 | +13.9% | 0.07% | +109.1% |
| Q4 2018 | $17,206,000 | -20.8% | 597,000 | 0.0% | 0.03% | -5.7% |
| Q3 2018 | $21,725,000 | -4.0% | 597,000 | -0.3% | 0.04% | -10.3% |
| Q2 2018 | $22,639,000 | +63.3% | 598,900 | +1.5% | 0.04% | +56.0% |
| Q1 2018 | $13,865,000 | +33.0% | 590,000 | +10.9% | 0.02% | +38.9% |
| Q4 2017 | $10,423,000 | +1451.0% | 532,049 | +660.1% | 0.02% | +1700.0% |
| Q3 2017 | $672,000 | +55.2% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $433,000 | +6.9% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $405,000 | +3.3% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $392,000 | -35.9% | 70,000 | -12.5% | 0.00% | 0.0% |
| Q3 2016 | $612,000 | -48.1% | 80,000 | -50.0% | 0.00% | 0.0% |
| Q2 2016 | $1,180,000 | +17.6% | 160,000 | +89.6% | 0.00% | -50.0% |
| Q1 2016 | $1,003,000 | – | 84,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,241,500 | $8,330,465 | 2.81% |
| Nantahala Capital Management | 3,023,799 | $20,289,691 | 1.73% |
| AlphaCentric Advisors LLC | 391,500 | $2,626,965 | 1.49% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 828,201 | $414,741 | 1.06% |
| TANG CAPITAL MANAGEMENT LLC | 935,800 | $6,279,218 | 0.89% |
| 683 Capital Management, LLC | 1,575,000 | $10,568,250 | 0.82% |
| Privium Fund Management B.V. | 281,606 | $1,889,576 | 0.56% |
| SANDERS MORRIS HARRIS LLC | 368,095 | $2,313,592 | 0.48% |
| Ghost Tree Capital, LLC | 215,000 | $1,442,650 | 0.47% |
| Sonic GP LLC | 50,000 | $335,500 | 0.33% |